Article · Volume 3, Issue 2 · pp. 155–162

Regulatory Aspects of Pharmaceuticals’ Exports in Gulf Cooperation Council Countries

Pateriya S¹, Janodia MD², Deshpande PB², Ligade VS², Talole KB², Kulshrestha T³, Kamariya Y³, Musmade PB², Udupa N²

¹Department of Advanced Pharmaceutical Studies, Manipal University, Manipal, INDIA.
²Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, INDIA.
³Zydus Research Center, Ahmedabad, INDIA.

Abstract

The Gulf cooperation council (GCC) region is considered as “Emerging market” for pharmaceutical export and bilateral trade. The understanding of the regulatory requirements of this region can be beneficial for pharmaceutical export. Some incidents of the year 2008-09, like recession or economic slowdown in highly well-off and regulated market of the EU and US, raised the demand for alternate destinations for business. The regulations of Gulf countries are encouraging the import of quality generic products, which can be good news to the Indian drug manufacturers.

Keywords: Exports; Gulf cooperation council; pharmaceutical; regulatory

The full text of this article is available as a PDF. Open the PDF.